Chest
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reilly, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reilly, J. J., Jr
(Chest. 1999;116:474S-476S.)
© 1999 American College of Chest Physicians

Evidence-Based Preoperative Evaluation of Candidates for Thoracotomy*

John J. Reilly, Jr, MD, FCCP

* From the Division of Pulmonary and Critical Care, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA

Correspondence to: John J. Reilly, Jr, MD, FCCP, Associate Professor of Medicine, Harvard Medical School, Brigham and Women’s Hospital, 7S Francis Street, Boston, MA 02115.

1. All patients considered for thoracotomy should have preoperative spirometry. 2. Patients meeting the criteria outlined below should also have quantitative radionuclide perfusion scanning. 3. Patients felt to be at high risk on the basis of predicted postoperative FEV1 should be considered for exercise assessment. 4. If exercise assessment is performed, an MO2 of < 10–15 mL/kg/min or a predicted postoperative MO2 < 10 mL/kg/min identifies a patient at very high risk for complications and mortality. 5. Limited available data support the use of preoperative risk indices to identify patients at high risk (See Table 4 ). 6. Lung volume reduction surgery may provide new approaches in selected patients with significant obstructive lung disease and concomitant lung cancer.




This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
G. Olgac, A. Olcmen, and C. A. Kutlu
Is lactate dehydrogenase level really a reliable predictor of pulmonary morbidity than other co-morbid parameters following lung resection for NSCLC?
Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 732 - 733.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
Y. Ohno, H. Hatabu, T. Higashino, D. Takenaka, H. Watanabe, Y. Nishimura, M. Yoshimura, and K. Sugimura
Dynamic Perfusion MRI Versus Perfusion Scintigraphy: Prediction of Postoperative Lung Function in Patients with Lung Cancer
Am. J. Roentgenol., January 1, 2004; 182(1): 73 - 78.
[Abstract] [Full Text] [PDF]

Home page
 ICVTSHome page
G. Varela, M. F. Jimenez, N. Novoa, and P. Macri
Discordance between predicted postoperative forced expiratory volumes in one second (ppoFEV1) calculated before and after resection of bronchogenic carcinoma
Interactive CardioVascular and Thoracic Surgery, June 1, 2003; 2(2): 138 - 142.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Beccaria, A. Corsico, P. Fulgoni, M. C. Zoia, L. Casali, G. Orlandoni, and I. Cerveri
Lung Cancer Resection : The Prediction of Postsurgical Outcomes Should Include Long-term Functional Results
Chest, July 1, 2001; 120(1): 37 - 42.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Chest Physicians.